Literature DB >> 16998486

Structural analysis of kasugamycin inhibition of translation.

Barbara S Schuwirth1, J Michael Day, Cathy W Hau, Gary R Janssen, Albert E Dahlberg, Jamie H Doudna Cate, Antón Vila-Sanjurjo.   

Abstract

The prokaryotic ribosome is an important target of antibiotic action. We determined the X-ray structure of the aminoglycoside kasugamycin (Ksg) in complex with the Escherichia coli 70S ribosome at 3.5-A resolution. The structure reveals that the drug binds within the messenger RNA channel of the 30S subunit between the universally conserved G926 and A794 nucleotides in 16S ribosomal RNA, which are sites of Ksg resistance. To our surprise, Ksg resistance mutations do not inhibit binding of the drug to the ribosome. The present structural and biochemical results indicate that inhibition by Ksg and Ksg resistance are closely linked to the structure of the mRNA at the junction of the peptidyl-tRNA and exit-tRNA sites (P and E sites).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998486      PMCID: PMC2636691          DOI: 10.1038/nsmb1150

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  45 in total

1.  Differential inhibition of coliphage MS2 protein synthesis by ribosome-directed antibiotics.

Authors:  M Kozak; D Nathans
Journal:  J Mol Biol       Date:  1972-09-14       Impact factor: 5.469

2.  Differential effects of aminoglycosides on cistron-specific initiation of protein synthesis.

Authors:  A Okuyama; N Tanaka
Journal:  Biochem Biophys Res Commun       Date:  1972-11-15       Impact factor: 3.575

3.  Actions of aurintricarboxylate, kasugamycin, and pactamycin on Escherichia coli polysomes.

Authors:  P C Tai; B J Wallace; B D Davis
Journal:  Biochemistry       Date:  1973-02       Impact factor: 3.162

4.  Mechanism of kasugamycin resistance in Escherichia coli.

Authors:  T L Helser; J E Davies; J E Dahlberg
Journal:  Nat New Biol       Date:  1972-01-05

5.  Inhibition by kasugamycin of initiation complex formation on 30S ribosomes.

Authors:  A Okuyama; N Machiyama; T Kinoshita; N Tanaka
Journal:  Biochem Biophys Res Commun       Date:  1971-04-02       Impact factor: 3.575

6.  [Clinical use of Kasugamycin for urinary tract infections due to Pseudomonas aeruginosa].

Authors:  J Ishigami; Y Fukuda; S Hara
Journal:  J Antibiot B       Date:  1967-04

7.  The structure of kasugamycin hydrobromide by x-ray crystallographic analysis.

Authors:  T Ikekawa; H Umezawa; Y Iitaka
Journal:  J Antibiot (Tokyo)       Date:  1966-01       Impact factor: 2.649

8.  Kasugamycin, a new antibiotic.

Authors:  H Umezawa; M Hamada; Y Suhara; T Hashimoto; T Ikekawa
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

9.  Kasugamycin resistance: 30S ribosomal mutation with an unusual location on the Escherichia coli chromosome.

Authors:  P F Sparling
Journal:  Science       Date:  1970-01-02       Impact factor: 47.728

10.  The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites.

Authors:  J Shine; L Dalgarno
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

View more
  48 in total

1.  The novel kasugamycin 2'-N-acetyltransferase gene aac(2')-IIa, carried by the IncP island, confers kasugamycin resistance to rice-pathogenic bacteria.

Authors:  Atsushi Yoshii; Hiromitsu Moriyama; Toshiyuki Fukuhara
Journal:  Appl Environ Microbiol       Date:  2012-06-01       Impact factor: 4.792

2.  A 5'-terminal phosphate is required for stable ternary complex formation and translation of leaderless mRNA in Escherichia coli.

Authors:  Jacqueline Giliberti; Sean O'Donnell; William J Van Etten; Gary R Janssen
Journal:  RNA       Date:  2012-01-30       Impact factor: 4.942

3.  Proximity of the start codon to a leaderless mRNA's 5' terminus is a strong positive determinant of ribosome binding and expression in Escherichia coli.

Authors:  Karthik M Krishnan; William J Van Etten; Gary R Janssen
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

Review 4.  Expanding the nucleotide repertoire of the ribosome with post-transcriptional modifications.

Authors:  Christine S Chow; Tek N Lamichhane; Santosh K Mahto
Journal:  ACS Chem Biol       Date:  2007-09-21       Impact factor: 5.100

5.  Fluorescently labeled ribosomes as a tool for analyzing antibiotic binding.

Authors:  Beatriz Llano-Sotelo; Robyn P Hickerson; Laura Lancaster; Harry F Noller; Alexander S Mankin
Journal:  RNA       Date:  2009-06-24       Impact factor: 4.942

6.  Control of glutamate receptor 2 (GluR2) translational initiation by its alternative 3' untranslated regions.

Authors:  Hasan A Irier; Yi Quan; Justin Yoo; Raymond Dingledine
Journal:  Mol Pharmacol       Date:  2009-09-30       Impact factor: 4.436

7.  Dimethyl adenosine transferase (KsgA) deficiency in Salmonella enterica Serovar Enteritidis confers susceptibility to high osmolarity and virulence attenuation in chickens.

Authors:  Kim Lam Chiok; Tarek Addwebi; Jean Guard; Devendra H Shah
Journal:  Appl Environ Microbiol       Date:  2013-10-11       Impact factor: 4.792

8.  An unexpected type of ribosomes induced by kasugamycin: a look into ancestral times of protein synthesis?

Authors:  Anna Chao Kaberdina; Witold Szaflarski; Knud H Nierhaus; Isabella Moll
Journal:  Mol Cell       Date:  2009-01-30       Impact factor: 17.970

9.  The chlamydial functional homolog of KsgA confers kasugamycin sensitivity to Chlamydia trachomatis and impacts bacterial fitness.

Authors:  Rachel Binet; Anthony T Maurelli
Journal:  BMC Microbiol       Date:  2009-12-31       Impact factor: 3.605

10.  Structural motifs of the bacterial ribosomal proteins S20, S18 and S16 that contact rRNA present in the eukaryotic ribosomal proteins S25, S26 and S27A, respectively.

Authors:  Alexey A Malygin; Galina G Karpova
Journal:  Nucleic Acids Res       Date:  2009-12-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.